Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.

Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.

Duchenne Muscular Dystrophy (DMD) is a fatal muscle wasting disorder caused by dystrophin deficiency. Previous work suggested that increased expression of the dystrophin-related protein utrophin in the mdx mouse can reduce the dystrophic pathophysiology. Physiological tests showed that the transgeni...

Bibliografiset tiedot
Päätekijät:	Baban, D, Davies, K
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2008

Samankaltaisia teoksia

Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO
Tekijä: Yin, H, et al.
Julkaistu: (2010)

Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice.
Tekijä: Rafael, J, et al.
Julkaistu: (2000)

Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system.
Tekijä: Squire, S, et al.
Julkaistu: (2002)

A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
Tekijä: Yin, H, et al.
Julkaistu: (2009)

Rescu of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping
Tekijä: Goyenvalle, A, et al.
Julkaistu: (2010)

Non-toxic ubiquitous over-expression of utrophin in the mdx mouse.
Tekijä: Fisher, R, et al.
Julkaistu: (2001)

Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy
Tekijä: Perkins, K, et al.
Julkaistu: (2018)

Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
Tekijä: Wakefield, P, et al.
Julkaistu: (2000)

Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.
Tekijä: Goyenvalle, A, et al.
Julkaistu: (2010)

Non-toxic ubiquitous overexpression of utrophin in the mdx mouse.
Tekijä: Fisher, R, et al.
Julkaistu: (2000)

Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
Tekijä: Griffin, J, et al.
Julkaistu: (2002)

Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment
Tekijä: Betts, C, et al.
Julkaistu: (2018)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping
Tekijä: Goyenvalle, A, et al.
Julkaistu: (2012)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
Tekijä: Goyenvalle, A, et al.
Julkaistu: (2012)

The utrophin and dystrophin genes share similarities in genomic structure.
Tekijä: Pearce, M, et al.
Julkaistu: (1993)

A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle.
Tekijä: Weir, A, et al.
Julkaistu: (2002)

A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.
Tekijä: Weir, A, et al.
Julkaistu: (2004)

Micro-utrophin improves cardiac and skeletal muscle function of severely affected D2/mdx mice
Tekijä: Kennedy, T, et al.
Julkaistu: (2018)

Immunogold confirmation that utrophin is localized to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle.
Tekijä: Culle, M, et al.
Julkaistu: (2001)

Up-regulation of utrophin alleviates the dystrophic phenotype in the mdx mouse heart
Tekijä: Sang, E, et al.
Julkaistu: (2000)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
Tekijä: Guiraud, S, et al.
Julkaistu: (2019)

Data on uncoupling protein-3 levels, hypoxia, low flow ischemia, and insulin stimulation in dystrophin-deficient mdx mouse hearts
Tekijä: Zhang, W, et al.
Julkaistu: (2018)

Confirmation by immunogold labeling that utrophin is localised to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle
Tekijä: Cullen, M, et al.
Julkaistu: (2001)

Effect of rapamycin on immunity induced by vector-mediated dystrophin expression in mdx skeletal muscle
Tekijä: Eghtesad, Saman, et al.
Julkaistu: (2014)

Generation of clusters of dystrophin revertant fibers requires muscle regeneration and tests the function of dystrophin/utrophin transgenes
Tekijä: Yokota, T, et al.
Julkaistu: (2004)

A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin.
Tekijä: Cole, M, et al.
Julkaistu: (2002)

Regulation of utrophin in transgenic mice.
Tekijä: Davies, K
Julkaistu: (2005)

Utrophin binds laterally along actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin-deficient muscle.
Tekijä: Rybakova, I, et al.
Julkaistu: (2002)

Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
Tekijä: Hanson, B, et al.
Julkaistu: (2022)

In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.
Tekijä: Aoki, Y, et al.
Julkaistu: (2010)

ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to beta-dystroglycan.
Tekijä: Ishikawa-Sakurai, M, et al.
Julkaistu: (2004)

Dystrophin and utrophin influence fiber type composition and post-synaptic membrane structure.
Tekijä: Rafael, J, et al.
Julkaistu: (2000)

Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin, utrophin and associated glycoproteins.
Tekijä: Moghadaszadeh, B, et al.
Julkaistu: (2003)

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice.
Tekijä: Yin, H, et al.
Julkaistu: (2011)

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice
Tekijä: Yin, H, et al.
Julkaistu: (2011)

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
Tekijä: Lu, Q, et al.
Julkaistu: (2003)

Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice.
Tekijä: Nakamura, A, et al.
Julkaistu: (2001)

Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.
Tekijä: Li, D, et al.
Julkaistu: (2010)

Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin
Tekijä: Li, D, et al.
Julkaistu: (2010)

Correlation of utrophin levels with the dystrophin protein complex and muscle fibre regeneration in Duchenne and Becker muscular dystrophy muscle biopsies
Tekijä: Janghra, N, et al.
Julkaistu: (2016)